These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 33777824)

  • 41. Iodine excess and hyperthyroidism.
    Roti E; Uberti ED
    Thyroid; 2001 May; 11(5):493-500. PubMed ID: 11396708
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative plasmapheresis in patients with Graves' disease intolerant to antithyroid drugs.
    Apaydin T; Gogas Yavuz D
    Ther Apher Dial; 2021 Dec; 25(6):877-883. PubMed ID: 33661574
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation and Management of Children with Thyrotoxicosis.
    Leung AKC; Leung AAC
    Recent Pat Endocr Metab Immune Drug Discov; 2017; 11(1):22-31. PubMed ID: 29589552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Amiodarone and the thyroid gland].
    Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
    Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amiodarone-induced thyrotoxicosis. A review.
    Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
    Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Approach to the patient with amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperthyroidism.
    De Leo S; Lee SY; Braverman LE
    Lancet; 2016 Aug; 388(10047):906-918. PubMed ID: 27038492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fighting thyrotoxicosis with therapeutic plasma exchange: A case report.
    Valverde Márquez Á; Mories Álvarez MT; Villanueva Alvarado HS; Vivas Vaca XC; Delgado Gómez M
    Endocrinol Diabetes Nutr (Engl Ed); 2024 Apr; 71(4):177-180. PubMed ID: 38735679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
    Gerber H; Noth D
    Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Brazilian consensus for the diagnosis and treatment of hyperthyroidism: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.
    Maia AL; Scheffel RS; Meyer EL; Mazeto GM; Carvalho GA; Graf H; Vaisman M; Maciel LM; Ramos HE; Tincani AJ; Andrada NC; Ward LS;
    Arq Bras Endocrinol Metabol; 2013 Apr; 57(3):205-32. PubMed ID: 23681266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Amiodarone-induced thyrotoxicosis].
    Bogazzi F; Tomisti L; Di Bello V; Martino E
    G Ital Cardiol (Rome); 2017 Mar; 18(3):219-229. PubMed ID: 28398380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refractory amiodarone-associated thyrotoxicosis: an indication for thyroidectomy.
    Claxton S; Sinha SN; Donovan S; Greenaway TM; Hoffman L; Loughhead M; Burgess JR
    Aust N Z J Surg; 2000 Mar; 70(3):174-8. PubMed ID: 10765898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Syndromes of thyrotoxicosis with low radioactive iodine uptake.
    Ross DS
    Endocrinol Metab Clin North Am; 1998 Mar; 27(1):169-85. PubMed ID: 9534035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of oral cholecystographic agents for the management of hyperthyroidism.
    Tyer NM; Kim TY; Martinez DS
    Endocr Pract; 2014 Oct; 20(10):1084-92. PubMed ID: 25100369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amiodarone-induced thyrotoxicosis: a review.
    Tsang W; Houlden RL
    Can J Cardiol; 2009 Jul; 25(7):421-4. PubMed ID: 19584973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative management in patients with Graves' disease.
    Piantanida E
    Gland Surg; 2017 Oct; 6(5):476-481. PubMed ID: 29142837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Challenges in the management of amiodarone-induced thyrotoxicosis].
    Tauveron I; Batisse-Lignier M; Maqdasy S
    Presse Med; 2018 Sep; 47(9):746-756. PubMed ID: 30274916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigational drugs in early stage clinical trials for thyrotoxicosis with hyperthyroidism.
    Gómez-Sáez JM
    Expert Opin Investig Drugs; 2018 Nov; 27(11):831-837. PubMed ID: 30354697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current approach to surgical management of hyperthyroidism.
    Barczyński M
    Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):124-131. PubMed ID: 33494587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical management of amiodarone-induced thyrotoxicosis.
    Franzese CB; Fan CY; Stack BC
    Otolaryngol Head Neck Surg; 2003 Nov; 129(5):565-70. PubMed ID: 14595280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.